Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Drugs - Real World Outcomes
|
July 11, 2020
Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
Nareen Krishna Polavarapu, Ravindra Kale, Bipin Sethi, et al.
Drugs - Real World Outcomes
|
October 29, 2023
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
Bipin Sethi, Rakesh Sahay, Mangesh Tiwaskar, et al.
Cardiovascular Diabetology. Endocrinology Reports
|
September 27, 2025
Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial
Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, et al.
Cardiovascular Diabetology. Endocrinology Reports
|
September 27, 2025
Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial
Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, et al.
Cureus
|
January 14, 2026
Expert Opinion of Empagliflozin Positioning in the Current Type 2 Diabetes Mellitus (T2DM) Landscape in Indian Patients
Bipin Sethi, Ashwani Mehta, Arundhati Dasgupta, et al.
Cureus
|
December 9, 2024
Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient Program
Bipin Sethi, Krishna Seshadri, Vaishali Deshmukh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 29, 2022
Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus
Bipin Sethi, A G Unnikrishnan, Vageesh Ayyar, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
July 8, 2021
Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
Viswanathan Mohan, Abdul Zargar, Manoj Chawla, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 8, 2025
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
Viswanathan Mohan, Bipin Sethi, Sunil M Jain, et al.
Indian Journal of Endocrinology and Metabolism
|
February 24, 2016
Diabetes insipidus: The other diabetes
Sanjay Kalra, Abdul Hamid Zargar, Sunil M Jain, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Drugs - Real World Outcomes
|
July 11, 2020
Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
Nareen Krishna Polavarapu, Ravindra Kale, Bipin Sethi, et al.
Drugs - Real World Outcomes
|
October 29, 2023
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database Study
Bipin Sethi, Rakesh Sahay, Mangesh Tiwaskar, et al.
Cardiovascular Diabetology. Endocrinology Reports
|
September 27, 2025
Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial
Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, et al.
Cardiovascular Diabetology. Endocrinology Reports
|
September 27, 2025
Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial
Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, et al.
Cureus
|
January 14, 2026
Expert Opinion of Empagliflozin Positioning in the Current Type 2 Diabetes Mellitus (T2DM) Landscape in Indian Patients
Bipin Sethi, Ashwani Mehta, Arundhati Dasgupta, et al.
Cureus
|
December 9, 2024
Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient Program
Bipin Sethi, Krishna Seshadri, Vaishali Deshmukh, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
June 29, 2022
Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus
Bipin Sethi, A G Unnikrishnan, Vageesh Ayyar, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
|
July 8, 2021
Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
Viswanathan Mohan, Abdul Zargar, Manoj Chawla, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 8, 2025
Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study
Viswanathan Mohan, Bipin Sethi, Sunil M Jain, et al.
Indian Journal of Endocrinology and Metabolism
|
February 24, 2016
Diabetes insipidus: The other diabetes
Sanjay Kalra, Abdul Hamid Zargar, Sunil M Jain, et al.
Page
of 4